期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 14, 期 11, 页码 1305-1318出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.14.11.1305
关键词
bilirubin; carbon monoxide; carbon monoxide-releasing molecules; cardiovascular disease; haem oxygenase-1; inflammation; kidney disease; oxidative stress; vasorelaxation
Carbon monoxide (CO), which is formed in mammalian cells through the oxidation of haem by the enzyme haem oxygenase, actively participates in the regulation of key intracellular functions. Emerging evidence reveals that an increased generation of haem oxygenase-derived CO plays a critical role in the resolution of inflammatory processes and alleviation of cardiovascular disorders. The authors have identified a novel class of substances, CO-releasing molecules (CO-RMs), which are capable of exerting a variety of pharmacological activities via the liberation of controlled amounts of CO in biological systems. A wide range of CO carriers containing manganese (CORM-1), ruthenium (CORM-2 and -3), boron (CORM-A1) and iron (CORM-F3) are currently being investigated to tailor therapeutic approaches for the prevention of vascular dysfunction, inflammation, tissue ischaemia and organ rejection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据